Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 3/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.63 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.63 |
| ▸ | PLAU | P00749 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.59 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | PLG | P00747 | 1/20 | 0.58 |
| ▸ | PLAT | P00750 | 1/20 | 0.58 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.58 |
| ▸ | KLK1 | P06870 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.58 |
| ▸ | JAK2 | O60674 | 1/20 | 0.56 |
| ▸ | JAK1 | P23458 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364540 | 1.00 | HDAC2 (0.63) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL27498643 | 0.86 | HDAC2 (0.59) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL11200897 | 0.86 | HDAC2 (0.59) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL24124203 | 0.86 | HDAC1 (0.49) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL11325167 | 0.85 | KMT2A (0.55) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL9116112 | 0.85 | HDAC2 (0.58) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL6809737 | 0.85 | KMT2A (0.60) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL11485725 | 0.85 | HDAC2 (0.58) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL6810362 | 0.85 | HDAC2 (0.62) | HDAC2HDAC1HDAC3NCOR2PLAU | |
| SCHEMBL6814507 | 0.85 | MAPT (0.59) | HDAC2HDAC1HDAC3NCOR2PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1576093-A4 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS INC (US) | 2009-07-08 | — | — | EP | claimed |
| CN-101084235-A | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS INC (US) | 2007-12-05 | — | — | CN | claimed |
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | DYNAMIS THERAPEUTICS, INC. | 2007-03-22 | — | — | US | claimed |
| EP-1576093-A2 | 3-DEOXYGLUCOSONE AND SKIN | Dynamis Therapeutics, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | DYNAMIS THERAPEUTICS, INC. | 2005-07-21 | — | — | US | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| WO-2003089601-A2 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-4381210-A | Process for producing polyimide tubes | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1983-04-26 | — | — | US | claimed |
| WO-2026105418-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR WAFER | 三菱瓦斯化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| EP-4696736-A1 | POLYIMIDE RESIN PRECURSOR, POLYIMIDE RESIN, AND POLYIMIDE FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-02-18 | — | — | EP | disclosed |
| WO-2025121336-A1 | POLYIMIDE RESIN | 三菱瓦斯化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025121335-A1 | METHOD FOR PRODUCING POLYIMIDE VARNISH | 三菱瓦斯化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025121334-A1 | POLYIMIDE RESIN | 三菱瓦斯化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025084155-A1 | METHOD FOR PRODUCING POLYIMIDE RESIN | 三菱瓦斯化学株式会社 | 2025-04-24 | — | — | WO | disclosed |
| US-5112989-A | Process for producing unsaturated mono and dicarboxylic acid imide compound | MATSUSHITA ELECTRIC WORKS LTD. (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0387381-A1 | Process for producing unsaturated dicarboxylic acid imide compound | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |
| US-4138581-A | BRONCHODILATOR AGENTS, ADRENERGIC STIMULANTS | STERLING DRUGS INC. (US) | 1979-02-06 | — | — | US | disclosed |
| US-4138568-A | NITRO-O-PHENYLENEDIAMINE, UREA, HALOBENZENE SOLVENT | CIBA-GEIGY CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4008195-A | POLYESTER | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JA) | 1977-02-15 | — | — | US | disclosed |
| US-3936404-A | Aqueous baking varnishes from carboxylic polyester and carboxylic polyimide, and coated article | NITTO ELECTRIC INDUSTRIAL CO., LTD. (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | FN3K, PDXK, COLGALT1 | HDAC2 2294/4885HDAC1 1856/4885HDAC3 2331/4885 |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DPM1, G6PD, UGGT1 | HDAC2 1580/4885HDAC1 1097/4885HDAC3 713/4885 |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | AGER, GLA, GALE | HDAC2 2770/4885HDAC1 2120/4885HDAC3 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.